Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Shionogi Cash Flow from Operating Activities 2021-2023 | SGIOY

Shionogi annual/quarterly cash flow from operating activities history and growth rate from 2021 to 2023. Cash flow from operating activities can be defined as a company's cash flows from operations.
  • Shionogi cash flow from operating activities for the quarter ending December 31, 2023 was $0.229B, a 81.11% decline year-over-year.
  • Shionogi cash flow from operating activities for the twelve months ending December 31, 2023 was $0.841B, a 30.65% decline year-over-year.
  • Shionogi annual cash flow from operating activities for 2023 was $1.316B, a 44.89% increase from 2022.
  • Shionogi annual cash flow from operating activities for 2022 was $0.908B, a 11.37% decline from 2021.
  • Shionogi annual cash flow from operating activities for 2021 was $1.025B, a 15.47% decline from 2020.
  
Shionogi Annual Cash Flow Ops
(Millions of US $)
2023 $1,316
2022 $908
2021 $1,025
2020 $1,213
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $12.767B $3.014B
Shionogi & Co., Ltd. engages in the research, development, manufacture and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Its primary products Tivicay for HIV treatment; Mulpleta for the treatment of thrombocytopenia; Xofluza, an influenza drug; Symproic for opioid-induced constipation treatment and Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment. Shionogi & Co., Ltd. is based in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $82.791B 32.99
Takeda Pharmaceutical (TAK) Japan $44.196B 8.85
Astellas Pharma (ALPMY) Japan $22.250B 20.49
Sandoz Group AG (SDZNY) Switzerland $19.619B 0.00
United Therapeutics (UTHR) United States $16.079B 15.87
Summit Therapeutics (SMMT) United States $13.513B 0.00
Neurocrine Biosciences (NBIX) United States $12.554B 33.33
Catalent (CTLT) United States $10.704B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.989B 7.41
Orion OYJ (ORINY) Finland $6.848B 19.25
Ionis Pharmaceuticals (IONS) United States $5.740B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.521B 0.00
Corcept Therapeutics (CORT) United States $4.900B 37.21
Madrigal Pharmaceuticals (MDGL) United States $4.688B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.463B 0.00
PTC Therapeutics (PTCT) United States $3.128B 0.00
Dyne Therapeutics (DYN) United States $2.932B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.653B 15.30
Catalyst Pharmaceuticals (CPRX) United States $2.559B 20.34
Arrowhead Pharmaceuticals (ARWR) United States $2.450B 0.00
Soleno Therapeutics (SLNO) United States $2.166B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.878B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.732B 0.00
Ocular Therapeutix (OCUL) United States $1.728B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.710B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.620B 0.00
Harrow (HROW) United States $1.576B 0.00
Xencor (XNCR) United States $1.470B 0.00
Evotec AG (EVO) Germany $1.403B 0.00
Ardelyx (ARDX) United States $1.387B 0.00
ARS Pharmaceuticals (SPRY) United States $1.383B 0.00
Enliven Therapeutics (ELVN) United States $1.341B 0.00
Indivior (INDV) United States $1.282B 5.22
Cassava Sciences (SAVA) United States $1.247B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.243B 0.00
Collegium Pharmaceutical (COLL) United States $1.117B 6.41
Bioventus (BVS) United States $1.100B 35.74
Guardian Pharmacy Services (GRDN) United States $1.090B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.052B 0.00
Cronos Group (CRON) Canada $0.807B 0.00
Relay Therapeutics (RLAY) United States $0.765B 0.00
USANA Health Sciences (USNA) United States $0.700B 12.98
Tourmaline Bio (TRML) United States $0.679B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.663B 41.50
Exscientia (EXAI) United Kingdom $0.620B 0.00
Savara (SVRA) United States $0.599B 0.00
Korro Bio (KRRO) United States $0.566B 0.00
Larimar Therapeutics (LRMR) United States $0.540B 0.00
Silence Therapeutics (SLN) United Kingdom $0.519B 0.00
Aquestive Therapeutics (AQST) United States $0.514B 0.00
Siga Technologies (SIGA) United States $0.505B 6.05
Verve Therapeutics (VERV) United States $0.490B 0.00
ProKidney (PROK) United States $0.487B 0.00
KalVista Pharmaceuticals (KALV) United States $0.484B 0.00
Xeris Biopharma Holdings (XERS) United States $0.481B 0.00
Altimmune (ALT) United States $0.480B 0.00
OmniAb (OABI) United States $0.471B 0.00
Elite Pharmaceuticals (ELTP) United States $0.465B 43.50
Zevra Therapeutics (ZVRA) United States $0.444B 0.00
4D Molecular Therapeutics (FDMT) United States $0.430B 0.00
Esperion Therapeutics (ESPR) United States $0.418B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.414B 0.00
Sage Therapeutics (SAGE) United States $0.394B 0.00
Organogenesis (ORGO) United States $0.383B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.359B 0.00
Akebia Therapeutics (AKBA) United States $0.357B 0.00
Aldeyra Therapeutics (ALDX) United States $0.317B 0.00
Lexeo Therapeutics (LXEO) United States $0.274B 0.00
Heron Therapeutics (HRTX) United States $0.273B 0.00
Avita Medical (RCEL) United States $0.270B 0.00
Acrivon Therapeutics (ACRV) United States $0.259B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.251B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.243B 0.00
Nature's Sunshine Products (NATR) United States $0.240B 16.44
ESSA Pharma (EPIX) Canada $0.234B 0.00
Nektar Therapeutics (NKTR) United States $0.230B 0.00
Pyxis Oncology (PYXS) United States $0.224B 0.00
Lyell Immunopharma (LYEL) United States $0.220B 0.00
Nanobiotix S.A (NBTX) France $0.206B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.200B 0.00
MediWound (MDWD) Israel $0.195B 0.00
Profound Medical (PROF) Canada $0.184B 0.00
Innate Pharma SA (IPHYF) France $0.180B 0.00
Context Therapeutics (CNTX) United States $0.163B 0.00
Achieve Life Sciences (ACHV) Canada $0.162B 0.00
Fractyl Health (GUTS) United States $0.161B 0.00
CytoDyn (CYDY) United States $0.160B 0.00
Galectin Therapeutics (GALT) United States $0.157B 0.00
Cardiol Therapeutics (CRDL) Canada $0.145B 0.00
Incannex Healthcare (IXHL) Australia $0.144B 0.00
VAXART, INC (VXRT) United States $0.139B 0.00
Telomir Pharmaceuticals (TELO) United States $0.131B 0.00
Aclaris Therapeutics (ACRS) United States $0.128B 0.00
Journey Medical (DERM) United States $0.119B 0.00
Century Therapeutics (IPSC) United States $0.108B 0.00
OptiNose (OPTN) United States $0.106B 0.00
Relmada Therapeutics (RLMD) United States $0.106B 0.00
Karyopharm Therapeutics (KPTI) United States $0.105B 0.00
AlloVir (ALVR) United States $0.102B 0.00
Regulus Therapeutics (RGLS) United States $0.102B 0.00
Assertio Holdings (ASRT) United States $0.100B 17.50
CASI Pharmaceuticals (CASI) China $0.095B 0.00
Arch Biopartners (ACHFF) Canada $0.089B 0.00
PMV Pharmaceuticals (PMVP) United States $0.082B 0.00
Metagenomi (MGX) United States $0.079B 0.00
ElectroCore (ECOR) United States $0.077B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.67
Vivani Medical (VANI) United States $0.074B 0.00
Citius Pharmaceuticals (CTXR) United States $0.073B 0.00
Prelude Therapeutics (PRLD) United States $0.073B 0.00
Nutriband (NTRB) United States $0.069B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
Champions Oncology (CSBR) United States $0.052B 0.00
SCYNEXIS (SCYX) United States $0.051B 0.00
Protara Therapeutics (TARA) United States $0.048B 0.00
Unicycive Therapeutics (UNCY) United States $0.048B 0.00
Inotiv (NOTV) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
ProPhase Labs (PRPH) United States $0.043B 0.00
DURECT (DRRX) United States $0.042B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
Surrozen (SRZN) United States $0.036B 0.00
Oruka Therapeutics (ORKA) United States $0.035B 0.00
BioLineRx (BLRX) Israel $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
GlycoMimetics (GLYC) United States $0.029B 0.00
Lipocine (LPCN) United States $0.029B 0.00
Natural Alternatives (NAII) United States $0.029B 0.00
Iterum Therapeutics (ITRM) Ireland $0.027B 0.00
BioVie (BIVI) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 0.72
Inhibikase Therapeutics (IKT) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
Talphera (TLPH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.015B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.015B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Indaptus Therapeutics (INDP) United States $0.013B 0.00
CERo Therapeutics Holdings (CERO) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.005B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.10
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.46
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 34.96